Literature DB >> 19328417

Thyroid-associated orbitopathy: who and how to treat.

Jane Dickinson1, Petros Perros.   

Abstract

Thyroid-associated orbitopathy is the most frequent and troublesome nonthyroidal complication of Graves' disease. It is mandatory to determine whether sight-threatening orbitopathy is present, as this requires prompt and aggressive treatment. Therapies for non-sight-threatening disease range from supportive measures only to medical therapies for active eye disease and surgical rehabilitation for burnt-out disease. Intravenous steroids and orbital radiotherapy are the mainstays of medical therapy. Rehabilitative surgery is frequently a staged process that may involve sequentially: orbital decompression, strabismus surgery, and eyelid procedures. Smoking cessation is recommended at all disease stages. Treatment within a multidisciplinary team consisting of both endocrinologists and ophthalmologists may lead to optimal patient outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 19328417     DOI: 10.1016/j.ecl.2009.01.004

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  7 in total

1.  Factors associated with severity of orbitopathy in patients with Graves' disease.

Authors:  Tauseef Nabi; Nadeema Rafiq
Journal:  Taiwan J Ophthalmol       Date:  2020-05-04

2.  Diagnostic accuracy of short-time inversion recovery sequence in Graves' Ophthalmopathy before and after prednisone treatment.

Authors:  Fabio Tortora; Mariaevelina Prudente; Mario Cirillo; Andrea Elefante; Maria Paola Belfiore; Francesco Romano; Salvatore Cappabianca; Carlo Carella; Sossio Cirillo
Journal:  Neuroradiology       Date:  2014-02-27       Impact factor: 2.804

3.  Disease activity in Graves' ophthalmopathy: diagnosis with orbital MR imaging and correlation with clinical score.

Authors:  Fabio Tortora; Mario Cirillo; Marco Ferrara; Maria Paola Belfiore; Carlo Carella; Ferdinando Caranci; Sossio Cirillo
Journal:  Neuroradiol J       Date:  2013-11-07

4.  Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy.

Authors:  Diego Strianese; Francesca Rossi
Journal:  Eye (Lond)       Date:  2019-01-04       Impact factor: 3.775

Review 5.  Thyroid-associated Ophthalmopathy.

Authors:  Esra Şahlı; Kaan Gündüz
Journal:  Turk J Ophthalmol       Date:  2017-04-01

6.  Elevated pulse pressure correlated with reduced retinal peripapillary capillary in thyroid-associated ophthalmology with visual field defect.

Authors:  Jie Ye; Weijie Liu; Xiaozhou Hu; Hongxiao Jiang; Mingna Xu; Haochen Jin; Mengting Wang; Zihui Liu; Qi Chen; Wencan Wu; Yunhai Tu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-16       Impact factor: 6.055

7.  Extraocular muscle sampled volume in Graves' orbitopathy using 3-T fast spin-echo MRI with iterative decomposition of water and fat sequences.

Authors:  Ludovico M Garau; Daniele Guerrieri; Flaminia De Cristofaro; Alice Bruscolini; Giuseppe Panzironi
Journal:  Acta Radiol Open       Date:  2018-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.